Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
|
CN |
|
C
|
Canadian Net Real Estate Investment Trust
XTSX:NET.UN
|
CA |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
IN |
|
Saudi Arabian Cooperative Insurance Company SJSC
SAU:8100
|
SA |
|
Taiwan Taffeta Fabric Co Ltd
TWSE:1454
|
TW |
Wall Street
Price Targets
Price Targets Summary
Suzhou Zelgen Biopharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for
Suzhou Zelgen Biopharmaceuticals Co Ltd
is 158.69 CNY
with a low forecast of 146.45 CNY and a high forecast of 174.47 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Suzhou Zelgen Biopharmaceuticals Co Ltd's stock price target?
Price Target
158.69
CNY
According to Wall Street analysts, the average 1-year price target for
Suzhou Zelgen Biopharmaceuticals Co Ltd
is 158.69 CNY
with a low forecast of 146.45 CNY and a high forecast of 174.47 CNY.
What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
63%
The
compound annual growth rate
of Suzhou Zelgen Biopharmaceuticals Co Ltd's revenue for the next 3 years is
63%.
